Impact of Skeletal Muscle Mass on Metabolic Health
Endocrinology and Metabolism
;
: 1-6, 2020.
Artículo
en Inglés
| WPRIM
| ID: wpr-816635
ABSTRACT
Skeletal muscle is regarded as an endocrine and paracrine organ. Muscle-derived secretory proteins, referred to as myokines, mediate interactions between skeletal muscle mass and other organs such as the liver, adipose tissue, pancreas, bone, and the cardiovascular system. As individuals age, reduced levels of physical activity and sarcopenia (loss of skeletal muscle mass and strength) are associated with physical frailty and disability. Recently, several studies have suggested that the loss of skeletal muscle mass may contribute to metabolic disease. Therefore, herein, we focus on the relationships between skeletal muscle mass and metabolic diseases, including metabolic syndrome and non-alcoholic fatty liver disease.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Páncreas
/
Sistema Cardiovascular
/
Tejido Adiposo
/
Músculo Esquelético
/
Sarcopenia
/
Enfermedad del Hígado Graso no Alcohólico
/
Hígado
/
Enfermedades Metabólicas
/
Actividad Motora
Idioma:
Inglés
Revista:
Endocrinology and Metabolism
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS